Category: Business Executive

Amicus Therapeutics And Their Growing Business

Amicus Therapeutics is one of the finest new biomed companies in the world, and they are focused on researching and releasing drugs that make a difference in the world. They have built a business based purely on the strength of their research, and they are hoping to release drugs to the public that will cure many diseases. This article explains how the company has invested in helping those who need it most.

#1: What Is The Purpose Of Biomed?

The biomed industry works with pharmaceuticals that will help cure illnesses from the cellular level. These companies are working on research that will help them create drugs that may be used in trials, and they hope that these drugs will go quite a long way to ensuring that the doctors and patients will see results(https://seekingalpha.com/article/4073303-amicus-therapeutics-small-biotech-seems-big-mo). They have many trusted partners, and they are looking into drugs that will cure a number of ailments.

#2: Trial Doctors Trust Amicus

Amicus Therapeutics has a number of trial doctors on their rolls that trust them with their patients. These doctors are given every opportunity to make a difference in the lives of patients, and they are reporting on drug trials that may change lives. They will participate in every new trial that Amicus has to offer, and they are giving the company a chance to bring the drug to a larger market.

#3: Growing Every Year

Amicus Therapeutics is growing every year in sales and trials(Yahoo Finance) . They want to have doctors working with them who are familiar with their work, and they want to help teach new doctors about the drugs they are building. This collaborative process works in favor of all patients, and patients who are lucky enough to be in their trials often see amazing results beyond anything they could have imagined.

Amicus Therapeutics has created a drug trial system that will grow their business and patient health. Their trial doctors help them release new drugs every year, and they are growing enough to release even more drugs to those who need them. Their commitment to biopharmaceuticals is unmatched across the industry.
More here:  Twitter | Facebook

Building Startup Companies Is a Small Segment of Mike Baur’s Passion for Succeeding

Mike Baur is not the type of businessman who looks for an overnight success. Following an impressive 20 year banking career, in 2014, Mike founded the Swiss Start Up Factory (SSUF) as a pivot for a brand new enterprise. As the Executive Chairman of the leading and most-prominent startup Company within Switzerland, Mike has created a platform for doing business in a way that is far from the traditional banking industry.

 

While many businessmen look to profit margins to guide their chosen industry, Mike chose his passion for inspiring and impacting people. Mike saw an opportunity to assist young entrepreneurs to find their way through the digital transformation era and believed that his level of enthusiasm and passion for doing business would be the perfect blend for producing startup companies.

 

Today, SSUF has the most sought-after program within Switzerland for young businesses and entrepreneurs to seek an opportunity where they can also receive capital. Swiss Start Up Factory increased its applicant receipts in 2016 by receiving 1,500 applications and 50 of those ultimately were batched within the startup program.

 

Those who are successfully selected into the program receive an exclusive level of coaching, mentoring, and they’re provided the office space to freely brain storm ideas as well as handle administrative business dealings. SSUF provides each team complete access to advanced technology that helps build the business infrastructure. Eventually, they’re paired with investors who are seeking new ventures to invest capital which Mike is heavily involved within the process.

 

Additionally, the SSUF program gives legal and financial guidance to support each phase of their new enterprise. The accelerator program was designed personally by Mike. Although Mike remains as the Executive Chairman of the company, he’s still actively involved in the process by providing mentoring to teams, and he provides the type of direction as a leader that keeps the momentum of the program continuing in the right direction.

 

Mike believes that talent is only part of the equation for succeeding in business. He says that bridging people’s talent with their passion is a perfect ingredient for success, but they also have to want to work hard for it.

 

One of the greatest assets of Mike is within his ability to lead. He has an extraordinary aspiration for wanting to see people succeed. Mike’s passion is his work, but it is also with helping entrepreneurs excel in their business and reaching their highest potential.

 

How Jeanmarie Guenot Is Shaping How We Treat Blood Born Illnesses

Ph. D Jeanmarie Guenot is a pharmaceutical expert who is dedicated to researching causes and treatments to multiple blood-borne illnesses such as autoimmune diseases and cancers. She is the CEO and President of Amphivera Therapeutics, a company that is responsible for developing and innovating new antibody treatments for these diseases. Despite her 20 years working in the medical field at https://www.takeda.com/news/2017/20170111_7659.html, she also has considerable experience in business and venture capitalism which makes her a perfect all-around role for wherever she may be situated.

Guenot work with Amphivera Therapeutics is perhaps the most interesting due to the nature of the work and the implications it can have on the future of medicine. The research done by the company is aimed at treating hematological cancers and diseases, such as leukemia. In fact, the company is responsible for developing the CD3 and AMV-364 which are used for treating myeloid leukemia. If left untreated, this disease can be fatal in a few short months, due to the rapid growth and spread of cancer cells in the bone marrow. However, with the development of drugs at Amphivera, this disease can become so much more treatable in the near future.

Dr. Jeanmarie Guenot also had a vital role at PDL Biopharma, where she was the Vice President in charge of licenses, as well as profits and losses. She was responsible for giving a license to biopharmaceutical company Ophthotech for an ophthalmic indication on a new oncology drug. She also was a part of a collaborative $800 million deal between PDL and Biogen that was to test certain cancer-fighting drugs on BusinessWire.com. The deal required several autoimmune drug candidates, as well as three Stage 2 cancer patients.

Utilizing the services provided by Amphivena Therapeutics means that people with deadly blood-borne cancers can have a second chance at life again. Mentioned on amphivena.com, the drugs developed within the company are fully researched to be safe while also being effective. As early as 20 years ago, we would not have had the technologies that we do today, and medical advancements are always being made. Soon, with the help of companies like Amphivena, diseases like cancer and leukemia will have an even lower mortality rate.

Capitol Anesthesiology Association Serving The Austin Area For Four Decades

Capitol Anesthesiology Association (CAA) was established in 1973 and now includes more than 80 physicians and 130 Certified Registered Nurse Anesthetists (CRNA) to provide the highest quality of care at over 20 medical facilities in Austin Texas. All physicians are board certified by the American Board of Anesthesiology or are in the process of obtaining this certification. The team of Doctors is assisted by CRNAs and anesthesia technicians to provide a safe and comfortable experience for all patients. CAA is a member of the Anesthesia Quality Institute and exemplifies their mission to improve anesthesia practices through education and data reporting.

Services provided by Capitol Anesthesiology Association are General Anesthesia, used to render the patient completely unconscious for extensive surgery; Regional Anesthesia, used to control pain sensitivity for a particular area before or after an operation; Local, used during procedures involving small areas; Pediatric Anesthesia, which required specialized training and certification; Obstetric Anesthesia, to assist with labor and delivery; and Cardiovascular and Thoracic Anesthesia, used in delicate surgeries involving the heart and lungs. CAA’s goal is to ensure each patient is given the best quality of care in both clinical and business activities. The administrative staff works with many insurance companies to make billing smoother.

The staff of CAA are strong supports of the community and continue to donate time and services to underserved areas around the world. Some of the organizations benefiting from this generosity are Austin Smiles, Dell Children’s Surgical Global Outreach, Operation Smile, Family Eldercare, and Children’s Medical Center Foundation.

Read full article: Click here.

Reasons to Take out a Loan From Equities First

One of the leading specialty finance firms in the world is Equities First. The company, which has been in business for around a decade, has already provided more than $1 billion in consumer loans to people across the United States, Europe, Asia, and the rest of the world. This also comes at a unique time when more traditional lenders have been cutting back on the level of consumer loans that they provide.

Equities First is a unique specialty finance firm that focuses on providing stock-secured consumer loans. When providing one of these loans to a borrower, the lender will be able to take a first lien position on an existing stock portfolio. Along with the lien, the lender will have the ability to liquidate the stock if the loan payments go into default. Due to this strong level of collateral, the lender is often willing to advance a loan at a high leverage point and charge a low interest rate.While paying interest on a loan secured by a liquid asset may not seem to make sense to some people, there are a lot of situations when it would make sense to take out a loan as opposed to selling the stock. One of the most common reasons to take out a loan is for tax planning purposes.

In the United States, there are a lot of tax benefits that come with waiting to sell a stock. In almost all cases, the interest on a loan will be much lower than the higher tax rate charged.Taking out a loan from Equities First is also a good idea for investment planning purposes. If you believe that the stock will be increasing in value in coming years, or the stock pays a strong dividend, it would make a lot of sense to wait to sell and to leverage the stock instead.

 

Mike Baur Promotes Startup Factory as it Continues to Expand

Mike Baur is a co-founder and Chairman of the Board at Swiss Start up Factory. He received an MBA from the University of Rochester, New York. He also earned an Executive MBA from the University of Berne. Mike spent over 20 years in the Swiss Private Banking industry. He started out as an apprentice at UBS. He worked his way up to serving on the executive board of a large Swiss Bank. He started Swiss Startup Factory in 2014, with his partner. They are the number 1 independent and privately financed ICT Startup Accelerator in Switzerland.

 

In addition to his work at Swiss Startup Factory, Mike spends a lot of time with Swiss youth entrepreneurs and serves as a mentor and also provides financial support. The Swiss Start Up Factory is located in Zurich. It is an accelerator, wanting to back and support, digital entrepreneurs. The company runs a three-month start up accelerator program for young entrepreneurs. They offer platform services, coaching mentoring and office space for rent in the middle of Zurich. They provide a network of entrepreneurs to counsel and guide the beginners.

 

The Start Up Factories mission is to help startups become global companies. They want to provide any new startup with all the services they need to reach success. Mike Baur is a frequent key note speaker at small and mid-sized companies, startup events and universities. They help startups go from ideas to the marketplace in 3 months. To reach this goal they offer face to face mentoring programs, a collaborative work environment, pitch training, and a network of connections to entrepreneurs and investors.

 

Mike has worked with many organizations that provide financial services to businesses. He served as Vice President of Innovation Lab Fribourg. The company supported engineering students, business students and natural sciences, to develop new ideas. Mike started out working for UBS from 1991 to 2000 in Wealth Management, He worked with UBS Bank in the Key Client Area from 2002 to 2008. He worked with Business Area Head of Private Banking with Clariden Leu, from 2008 to 2011.Mike was head of private banking at Clariden Leu, from 2011 to 2012. He was head of private banking at Sallfort Privatbank AG, from 2012 to 2014. Currently Mike is head of the Swiss Startup Factory and is involved in raising funds for the company.

Danilo Diaz-Granados Is A Venezuelan Business Genius According To His Wealthy Clients

What makes a great investment advisor? A degree in finance and economics certainly helps. But successful investment advisors need more than just a formal education. They need the innate qualities of curiosity and relentlessness as well as the ability to think about what’s next without losing track of what is now. Danilo Diaz Granados has all those qualities. Granados is a Venezuelan-born business genius that got a degree in economics from Babson College in Wellesley, Massachusetts. Granados doesn’t call himself a genius, however. But his clients that listen to his investment advice call him one.

Granados moved to Miami after graduation, and he landed a job with Firemen Capital Partners as an associate investment advisor. It didn’t take long for Danilo to show his initial clients his investment knowledge, and it didn’t take long for that list of Latino investors to grow. Latino investors liked his ideas and wanted to do more business with him. Granados was a natural when it came to finding the right investments for his clients. Granados have the ability to listen and then advise, and those abilities enhanced his reputation and his credibility.

But even though Miami was an economic boom town, the retail segment of that economy overlooked the wealthy Latinos that had lots of money but not enough time to shop around to spend it. Granados listened and watched his friends try to buy expensive items, but time got in the way and time was money to them. Danilo talked to friends about the void in the Latino retail market, and thanks to their input he decided to start a company called, Toys for Boys. Toys for Boys offered wealthy Latinos expensive products in one place. The elite Latinos that were pressed for time, not money, could visit his location and but exotic cars, expensive Swiss watches, Italian suits and shoes and other items they couldn’t find in Miami or anywhere else. His Toys for Boys idea was a hit, so Danilo decided to start a film company called Edge of Glory Films that documents Latino life. His Latino film adventure is still unfolding, but the potential is enormous thanks to his talent and his desire to succeed.  Be sure to follow Danilo on social media, including his Twitter @DaniloDiaz_G1, and his Instagram.

Kyle Bass May Be Gunning For China’s Economy

Influencing the economy is easy if the right soapbox can be found, maintained, and utilized. Kyle Bass has done exactly this on multiple occasions, and it seems he may be at it again.

Kyle Bass is an Argentine by heritage, though he runs his hedge fund out of liberal Austin, Texas. Hayman Capital Management has only ever had a mediocre performance. The more successful transactions of Bass tend toward deliberate market manipulation. Consider Bear-Stearns, Bass’ employer prior the 2008 financial meltdown. When their relationship dissolved, Bass dropped a tip to a financial journalist. By the end of the week, Bear-Stearns lost so much consumer confidence on Wall Street, J.P. Morgan-Chase had to buy them out. By September of that year, the Great Recession was hitting on all cylinders, and Bass had made millions short-selling sub-prime mortgages. He knew the collapse was coming from the inside, and kicked it off in a way through Bear-Stearns. Then he made money from it.

Now consider CAD, the Coalition for Affordable Drugs. This is Bass’ pseudo-humanitarian organization; a group used to manipulate through any possible means the law. The aim is forcing pharmaceuticals into lowering their drug costs. Bass has managed to do this successfully several times. When the price-drop hits, stock value drops, and he again short-sells, making millions.  There’s more information about it in the UsefulStooges article Kyle Bass The Frantic Investments of a Desperate Gambler.

Bass is regularly involved with Cristina Fernandez de Kirchner, the socialist leader of Argentina. Cristina is called a despot by many, and for good reason: her bad financial dealings have defaulted the country twice in only thirteen years.

With these things in mind, when Kyle Bass mentions China, and then says he expects a credit bubble burst in the next two to three years, understand he may be right; but there’s as much a likelihood he’s working some angle. Consider his comments. He started descrying China’s economy in 2015, October. By April, he was saying there was a forty to fifty percent chance of economic collapse. In a recent Bloomberg article, he reportedly said that if China “materially” devalues their currency, it could be one of the most historically exciting times to invest in Asia. Bass has basically said: “China could do good, or bad.” But he’s put a negative lingo-spin on it, so un-savvy investors may curtail investiture, artificially facilitating the decline he prophecies.

Duda Melzer – RBS Group’s New Executive President

In a live broadcast to the over 6400 employees, Duda Melzer officially took over as Executive President of the RBS Group on Tuesday, June 3rd, and strengthened his commitment to the Group’s technological development while still retaining the human dimension in the three pillars of its business – communications, digital, and business education.

Retaining the Group’s core values is extremely important to Eduardo Sirotsky Melzer,, who stressed that his greatest commitment was to ensure that RBS was a special place for all of them to work. “I am fascinated with the soul of this company, with the dynamism of our industry, but mainly by the impact of it in the lives of people. I learned that this is a company driven by challenges, made by people passionate about what they do”, Melzer stated in his address.

Nelson Sirotsky, the former Executive President and Melzer’s uncle, will remain on the Board of Directors and the Editorial Committee of RBS Group. Sirotsky has been with the company for 41 years, the last 21 of which were as head of the Group’s Executive Presidency. Despite his different role, Nelson Sirotsky will still be critical to the success of the Group’s management.

The inaugural ceremony was attended by 450 people, with Yamandu Costa performing the National Anthem, and Fernanda Montenegro delighted the entire celebration. The event also included RBS company history, photos, and tributes, including a memorable tribute to Ione Sirotsky, wife of RBS’ founder Mauricio Sirotsky Sobrinho (both now deceased), former company Presidents Jayme Sirotsky and Nelson Sirotsky, and the new CEO, Eduardo Sirotsky Melzer.

Read more about Melzer here:

Sam Tabar’s Opinion on the Best Methods of Investing

Every person has his or her resolutions for every new year. Some individuals wish to change their bad habits while other have need to invest for them to be financially stable after retirement. At old age, a regular American would need to have about 75 to 80 percent of the income they had when they were still employed, for them to have a stable life. Achieving this is a little complicated, and therefore, it is necessary to seek professional advice from experts such as Sam Tabar.

Sam Tabar attended Oxford University and Columbia Law School where he got sufficient skills to practice as an attorney and capital strategist. He has been an employee of various companies, which include the Bank of America Merrill Lynch, where he served as a Director and a Capital Strategy Head for the firm’s Asian-Pacific units. He has also been an investment and hedge fund legal matters counselor to clients of New York-based firms, which include Schulte Roth & Zabel, and Skadden, Arps, Slater, Meagher & Flom. Mr. Tabar has outstanding knowledge on making and saving money.

One of the businesses that people can invest in to ensure financial stability is capitalizing on commodity investments. Individuals who want to get involved in this business need to be keen on the progress of markets before they start trading. The stock markets are usually very unstable due to fluctuating prices of the commodities. The share prices can be high on one day and greatly drop the next day hence leading to severe losses. As an expert, Sam Tabar advises individuals to ensure differentiation of stock portfolios while investing.  He’s now plying his trade as the COO of FullCycle Energy Fund.

Another business that Americans can invest in while preparing for retirement is the capitalizing their money on startups that are socially conscious. The business does not involve a lot of risk like in the stock markets. Examples of this companies are the Muhammed Yunus’s Grameen Bank. The firm provides small loans to financially stressed owners of small businesses in all parts of Southeastern Asia. THINX is also a socially responsible organization that manufactures panties that are used by women during menstruation. THINX is charitable and gives away seven sanitary pads for every “period pantie” that is sold. Sam Tabar is an investor in the company. PR Newswire has a similar article on Mr. Tabar.